• Firm commitments received to raise $0.8M through a share placement at $0.005 per share
• Placement strongly supported by new and existing sophisticated and professional investors
• Proceeds to support Felix's commercial execution, including expansion of direct selling, manufacturing, and regulatory progression

Memphasys Limited (ASX: MEM) has announced that it has secured firm commitments from sophisticated and professional investors to raise $0.8M (before costs) through a share placement at an issue price of $0.005 per share. The placement was strongly supported by both new and existing institutional, sophisticated, and professional investors. The proceeds from the placement will be used to support the commercial execution of Memphasys' Felix System, including the expansion of the direct selling model, manufacturing cartridges to meet growing customer demand, regulatory progression, and working capital as the company advances recent commercial and regulatory milestones. The placement comprises the issue of a total of 160,000,000 fully paid ordinary shares, representing a 28.6% discount to the last trading price and a 22.5% discount to the 10-day volume-weighted average price. The new shares will rank equally with existing Memphasys shares. Settlement of the placement is expected to occur on 13 February 2026, with the shares to be allotted on or around 16 February 2026. Lynx Advisors Pty Ltd acted as the Lead Manager to the placement.